Search Results - "Kanters, Tim"

Update of the Dutch manual for costing studies in health care by Kanters, Tim A, Bouwmans, Clazien A M, van der Linden, Naomi, Tan, Siok Swan, Hakkaart-van Roijen, Leona

“…Dutch health economic guidelines include a costing manual, which describes preferred research methodology for costing studies and reference prices to ensure…”
Get full text

Benefits of a digital health technology for older nursing home residents. A de-novo cost-effectiveness model for digital health technologies to aid in the assessment of toileting and containment care needs by Abraham, Katharina, Kanters, Tim Andre, Wagg, Adrian Stuart, Huige, Nicole, Hutt, Edward, Al, Maiwenn Johanna

“…The aim of this study was first, to introduce a comprehensive, de-novo health economic (HE) model incorporating the full range of activities involved in…”
Get full text

Methodological Challenges in the Economic Evaluation of a Gene Therapy for RPE65-Mediated Inherited Retinal Disease: The Value of Vision by Huygens, Simone A., Versteegh, Matthijs M., Vegter, Stefan, Schouten, L. Jan, Kanters, Tim A.

“…The emergence of gene therapies challenge health economists to evaluate interventions that are often provided to a small patient population with a specific…”
Get full text

Orphan drugs expenditure in the Netherlands in the period 2006-2012 by Kanters, Tim A, Steenhoek, Adri, Hakkaart, Leona

“…The relatively low budget impact of orphan drugs is often used as an argument in reimbursement decisions. However, overall, the budget impact of orphan drugs…”
Get full text

Burden of Providing Informal Care for Patients with Atrial Fibrillation by Kanters, Tim A., Brugts, Jasper J., Manintveld, Olivier C., Versteegh, Matthijs M.

“…Patients with atrial fibrillation (AF) have rapid and irregular heart rates, increasing the risk of comorbidities and mortality. Next to formal medical care,…”
Get full text

Productivity of Working at Home and Time Allocation Between Paid Work, Unpaid Work and Leisure Activities During a Pandemic by Huls, Samare P. I., Sajjad, Ayesha, Kanters, Tim A., Hakkaart-van Roijen, Leona, Brouwer, Werner B. F., van Exel, Job

“…Background and Objective The COVID-19 pandemic and the measures taken by governments to contain it have affected many aspects of the daily lives of citizens…”
Get full text

Hospital-based or home-based administration of oncology drugs? A micro-costing study comparing healthcare and societal costs of hospital-based and home-based subcutaneous administration of trastuzumab by Franken, Margreet, Kanters, Tim, Coenen, Jules, de Jong, Paul, Jager, Agnes, Groot, Carin Uyl-de

“…To investigate resource use and time investments of healthcare professionals, patients and their family and to compare healthcare and societal costs of one…”
Get full text

Caregiver Burden and Quality of Life Across Alzheimer’s Disease Severity Stages by van Hezik-Wester, Valérie J., Handels, Ron L.H., Wolfs, Claire A.G., Kanters, Tim A.

“…The objective is to estimate the caregiver burden in terms of informal care time, health-related quality of life (HRQoL), and societal costs by disease…”
Get full text

Adoption of Biosimilar Infliximab for Rheumatoid Arthritis, Ankylosing Spondylitis, and Inflammatory Bowel Diseases in the EU5: A Budget Impact Analysis Using a Delphi Panel by Kanters, Tim A, Stevanovic, Jelena, Huys, Isabelle, Vulto, Arnold G, Simoens, Steven

“…Introducing biosimilar infliximab for the treatment in rheumatology (rheumatoid arthritis and ankylosing spondylitis) and inflammatory bowel disease (Crohn's…”
Get full text

The Disease Burden and Societal Costs of Hereditary Angioedema by Fijen, Lauré M, Klein, Philip C G, Cohn, Danny M, Kanters, Tim A

“…According to the current treatment guidelines, the goals of treatment of patients with hereditary angioedema (HAE) are to achieve total control of the disease…”
Get full text

Systematic review of available evidence on 11 high-priced inpatient orphan drugs by Kanters, Tim A, de Sonneville-Koedoot, Caroline, Redekop, W Ken, Hakkaart, Leona

“…Attention for Evidence Based Medicine (EBM) is growing, but evidence for orphan drugs is argued to be limited and inferior. This study systematically reviews…”
Get full text

Potential cost savings owing to the route of administration of oncology drugs: a microcosting study of intravenous and subcutaneous administration of trastuzumab and rituximab in the Netherlands by Franken, Margreet G, Kanters, Tim A, Coenen, Jules L, de Jong, Paul, Koene, Harry R, Lugtenburg, Pieternella J, Jager, Agnes, Uyl-de Groot, Carin A

“…There is little evidence on the costs associated with the route of administration of oncology drugs. We investigated time and resource use for hospitals and…”
Get full text

A cost of illness study of hypoglycaemic events in insulin-treated diabetes in the Netherlands by de Groot, Saskia, Enters-Weijnen, Catherine F, Geelhoed-Duijvestijn, Petronella H, Kanters, Tim A

“…ObjectivesPatients with diabetes mellitus are at a risk for hypoglycaemia. Besides the burden of hypoglycaemia for patients, hypoglycaemia poses an economic…”
Get full text

Burden of illness in people with medically refractory epilepsy who suffer from daily to weekly seizures: 12-month follow-up of participants in the EPISODE study by van Hezik-Wester, Valérie, de Groot, Saskia, Kanters, Tim, Versteegh, Matthijs, Wagner, Louis, Ardesch, Jacqueline, Brouwer, Werner, van Exel, Job

“…Background A small group of people with epilepsy suffers from frequent seizures despite the available pharmacological and non-pharmacological interventions…”
Get full text

Quality of life and participation in daily life of adults with Pompe disease receiving enzyme replacement therapy: 10 years of international follow-up by Güngör, Deniz, Kruijshaar, Michelle E., Plug, Iris, Rizopoulos, Dimitris, Kanters, Tim A., Wens, Stephan C. A., Reuser, Arnold J. J., van Doorn, Pieter A., van der Ploeg, Ans T.

“…Summary Background Pompe disease is an inheritable metabolic disorder for which enzyme replacement therapy (ERT) has been available since 2006. Effects of ERT…”
Get full text

Cost comparison of two implantable cardiac monitors in two different settings: Reveal XT in a catheterization laboratory vs. Reveal LINQ in a procedure room by Kanters, Tim A, Wolff, Claudia, Boyson, David, Kouakam, Claude, Dinh, Trang, Hakkaart, Leona, Rutten-Van Mölken, Maureen P M H

“…Implantable cardiac monitors (ICMs) are used for long-term heart rhythm monitoring, e.g. to diagnose unexplained syncope or for detection of suspected atrial…”
Get full text

Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in adult patients with Pompe disease by Kanters, Tim A, van der Ploeg, Ans T, Kruijshaar, Michelle E, Rizopoulos, Dimitris, Redekop, W Ken, Rutten-van Mӧlken, Maureen P M H, Hakkaart-van Roijen, Leona

“…Pompe disease is a rare, progressive, metabolic disease, and the first treatable inheritable muscle disorder. Enzyme replacement therapy (ERT) with…”
Get full text

Cost Effectiveness of Splenic Artery Embolization versus Splenectomy after Trauma in the Netherlands by Kanters, Tim A., Raaijmakers, Claudia P.A.M., Lohle, Paul N.M., de Vries, Jolanda, Hakkaart-van Roijen, Leona, Raaijmakers, C.P.A.M., Lohle, P.N.M., de Vries, J., van der Heijden, F.H.W.M., Schonenberg, C.H.J., Verhofstad, M.H.J., Moelker, A., de Graaff, H.P., Vroegindeweij, D., van der Vlies, C.H., Smit, K.C., Elgersma, O.E.H., Jakma, T.S.C., Roodenburg, H.S., Vos, L.D., Romme, P.J.H.J., Zielinski, S.M., Alberts, A.R., van der Slegt, J., van Rijswijk, C.S.P., Bartlema, K.A., Labadie, G., Meijerink, M.R., Zuidema, W.P., van Dam, C., Klazen, C.A.H., de Wit, R.J., Goolkate, A., Edwards, M.J.R., Dekker, H.M., Tromp, T., van Hasselt, B.A.A.M., van Helden, S.H., Buitenhuis, L.

“…To demonstrate that splenic artery embolization (SAE) is more cost-effective than splenectomy from a societal perspective in the Netherlands. Patient-level…”
Get full text

Decreased quality of life and societal impact of cryopyrin-associated periodic syndrome treated with canakinumab: a questionnaire based cohort study by Mulders-Manders, Catharina M, Kanters, Tim A, van Daele, Paul L A, Hoppenreijs, Esther, Legger, G Elizabeth, van Laar, Jan A M, Simon, Anna, Hakkaart-van Roijen, Leona

“…Cryopyrin-associated periodic syndrome (CAPS) is a rare disease. Knowledge on the quality of life (QoL) and the disease's societal impact is limited…”
Get full text

The impact of informal care for patients with Pompe disease: An application of the CarerQol instrument by Kanters, Tim A., van der Ploeg, Ans T., Brouwer, Werner B.F., Hakkaart, Leona

“…Patients with Pompe disease, a rare progressive neuromuscular disorder, receive a considerable amount of informal care. In this study, we examined the impact…”
Get full text